| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2006-05-22 14:17:42 UTC |
|---|
| Update Date | 2021-09-14 15:46:08 UTC |
|---|
| HMDB ID | HMDB0002224 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 5-Methyldeoxycytidine |
|---|
| Description | 5-Methyldeoxycytidine is a dinucleotide. Methylation of cytosine-guanine dinucleotide sequences (CpG dinucleotides) catalyzed by DNA methyltransferase, particularly in the 5′-promoter regions of mammalian genes, forms 5-methyldeoxycytidine (5-mdc) whose levels may regulate gene expression. Levels of 5-mdc and the expression of nm23-H1 (an anti-metastatic gene identified in and human cancer lines) are highly correlated with human hepatoma cells with different invasion activities. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. The levels of 5-mdc in the urine of patients with breast cancer is not significantly different than controls. (PMID: 17044778 , 17264127 , 16799933 ). |
|---|
| Structure | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N InChI=1S/C10H15N3O4/c1-5-3-13(10(16)12-9(5)11)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)/t6?,7-,8-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 2'-Deoxy-5-methylcytidine | HMDB | | 5-Methyl-2'-deoxycytidine | HMDB | | 5-Methyldeoxycytidine | MeSH |
|
|---|
| Chemical Formula | C10H15N3O4 |
|---|
| Average Molecular Weight | 241.2438 |
|---|
| Monoisotopic Molecular Weight | 241.106255983 |
|---|
| IUPAC Name | 4-amino-1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one |
|---|
| Traditional Name | 4-amino-1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one |
|---|
| CAS Registry Number | 838-07-3 |
|---|
| SMILES | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N |
|---|
| InChI Identifier | InChI=1S/C10H15N3O4/c1-5-3-13(10(16)12-9(5)11)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)/t6?,7-,8-/m1/s1 |
|---|
| InChI Key | LUCHPKXVUGJYGU-SPDVFEMOSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Nucleosides, nucleotides, and analogues |
|---|
| Class | Pyrimidine nucleosides |
|---|
| Sub Class | Pyrimidine 2'-deoxyribonucleosides |
|---|
| Direct Parent | Pyrimidine 2'-deoxyribonucleosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyrimidine 2'-deoxyribonucleoside
- Aminopyrimidine
- Pyrimidone
- Hydropyrimidine
- Pyrimidine
- Imidolactam
- Heteroaromatic compound
- Tetrahydrofuran
- Secondary alcohol
- Azacycle
- Oxacycle
- Organoheterocyclic compound
- Alcohol
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Primary amine
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.79 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.2369 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.44 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 72.3 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 539.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 220.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 82.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 155.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 59.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 283.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 256.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 433.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 600.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 90.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 775.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 166.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 181.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 495.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 281.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 166.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 5-Methyldeoxycytidine,1TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N | 2372.6 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,1TMS,isomer #2 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N | 2370.9 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,1TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N[Si](C)(C)C | 2447.6 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,2TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N | 2359.3 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,2TMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N[Si](C)(C)C | 2423.7 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,2TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C | 2416.2 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,2TMS,isomer #4 | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2403.0 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C | 2389.1 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C | 2439.6 | Standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C | 3063.2 | Standard polar | 33892256 | | 5-Methyldeoxycytidine,3TMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2402.4 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2558.8 | Standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 3040.8 | Standard polar | 33892256 | | 5-Methyldeoxycytidine,3TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2409.1 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2542.8 | Standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2964.9 | Standard polar | 33892256 | | 5-Methyldeoxycytidine,4TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2412.8 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,4TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2555.8 | Standard non polar | 33892256 | | 5-Methyldeoxycytidine,4TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2732.7 | Standard polar | 33892256 | | 5-Methyldeoxycytidine,1TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N | 2639.0 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,1TBDMS,isomer #2 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N | 2647.5 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,1TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2677.9 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,2TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N | 2835.7 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,2TBDMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2862.6 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,2TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2861.7 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,2TBDMS,isomer #4 | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2839.6 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3065.0 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3084.9 | Standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3246.9 | Standard polar | 33892256 | | 5-Methyldeoxycytidine,3TBDMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3071.5 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TBDMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3176.5 | Standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TBDMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3196.8 | Standard polar | 33892256 | | 5-Methyldeoxycytidine,3TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3064.0 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3164.1 | Standard non polar | 33892256 | | 5-Methyldeoxycytidine,3TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3161.7 | Standard polar | 33892256 | | 5-Methyldeoxycytidine,4TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3265.6 | Semi standard non polar | 33892256 | | 5-Methyldeoxycytidine,4TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3326.9 | Standard non polar | 33892256 | | 5-Methyldeoxycytidine,4TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3087.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methyldeoxycytidine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9420000000-4af773e99af76af961ea | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methyldeoxycytidine GC-MS (2 TMS) - 70eV, Positive | splash10-0006-9014000000-1fd11a88c9a0762a6b1d | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methyldeoxycytidine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 10V, Positive-QTOF | splash10-004i-0900000000-d1d23649ec4fa9201eba | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 20V, Positive-QTOF | splash10-004i-2900000000-d21a1bb287e1d523b6c2 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 40V, Positive-QTOF | splash10-004i-3900000000-b4f3cca0a164fdbc5031 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 10V, Negative-QTOF | splash10-0a4j-0920000000-6aa55dc948aac874e1a0 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 20V, Negative-QTOF | splash10-0uk9-2920000000-6d51e08eb5820a748902 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 40V, Negative-QTOF | splash10-007p-9400000000-77fb64e0199129096777 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 10V, Negative-QTOF | splash10-00dl-0970000000-a011cf5a5c3613811717 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 20V, Negative-QTOF | splash10-00dl-9600000000-ee60e868c938ff348f09 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 40V, Negative-QTOF | splash10-006y-9500000000-81204e67016c197ad16f | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 10V, Positive-QTOF | splash10-004i-0900000000-a1c51dd1d9ae2dee6e38 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 20V, Positive-QTOF | splash10-00b9-2900000000-7c9c6f54bbfba0acc135 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 40V, Positive-QTOF | splash10-0059-6900000000-9559671d86d852719546 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Cho SH, Jung BH, Lee SH, Lee WY, Kong G, Chung BC: Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2006 Nov;20(11):1229-36. [PubMed:16799933 ]
- Yang TH, Hu ML: Intracellular levels of S-adenosylhomocysteine but not homocysteine are highly correlated to the expression of nm23-H1 and the level of 5-methyldeoxycytidine in human hepatoma cells with different invasion activities. Nutr Cancer. 2006;55(2):224-31. [PubMed:17044778 ]
- Liu Z, Liu S, Xie Z, Blum W, Perrotti D, Paschka P, Klisovic R, Byrd J, Chan KK, Marcucci G: Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method. Nucleic Acids Res. 2007;35(5):e31. Epub 2007 Jan 30. [PubMed:17264127 ]
|
|---|